3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonists.
Title
3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonists.
Creator
Geldenhuys Werner J; Nakamura Hiroshi
Publisher
Bioorganic & medicinal chemistry letters
Date
2010
2010-03
Description
The transforming growth factor-beta (TGF-beta) is part of a family of cytokines which regulate various signaling pathways such as cell development, growth, and tissue injury. Although several studies have been published describing the synthesis of small compounds which inhibit the receptor of TGF-beta, especially the subtype 1 receptor (TGBR1) kinase, no 3D-quantitiative structure-activity relationship study has been published. Here we describe the development of a comparative molecular field analysis (CoMFA) model which yielded a partial least squares statistical cross validated r(2) of \textgreater0.3. CoMFA maps agree with docking studies and pharmacophore analysis that hydrogen bonding is important for binding to ALK-5. These studies could enable the medicinal chemist to develop novel inhibitors which can be used in glaucoma filtration surgery.
Subject
Models; Molecular; Quantitative Structure-Activity Relationship; Receptors; Transforming Growth Factor beta/*antagonists & inhibitors
Identifier
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Citation
Geldenhuys Werner J; Nakamura Hiroshi, “3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonists.,” NEOMED Bibliography Database, accessed April 26, 2024, https://neomed.omeka.net/items/show/3490.